Cibisatamab
Product Specifications
CAS Number
1855925-27-7
Target
Others|||Integrin
Related Pathways
Cytoskeletal Signaling|||Others
Purity
>99.1%
Bioactivity
Cibisatamab is a T-cell bispecific antibody that acts as a T-cell splicer.Cibisatamab targets carcinoembryonic antigen (CEA) on cancer cells and CD3 on T-cells, and triggers T-cell killing when the CEA on the surface of the cancer cells ranges from intermediate to high levels.Cibisatamab may be used to study solid cancers such as colorectal cancer.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7069763 Inquire
Recombinant Caenorhabditis elegans Serpentine receptor class delta-41 (srd-41), partial
Ask
View Details 